Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

The Food and Drug Administration's process for approving new drugs : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.
Published: (1979)

Drug lag : Federal Government decision making /
by: Ricardo-Campbell, Rita
Published: (1976)

The Food and Drug Administration's process for approving new drugs : report /
Published: (1980)

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.
Published: (1993)

Evaluating the effectiveness of the Food and Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
Published: (2001)

Evaluating the effectiveness of the Food And Drug Administration Modernization Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, May 3, 2001.
Published: (2001)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate /
by: Crosse, Marcia
Published: (2011)

Prescription drugs : FDA's oversight of the promotion of drugs for off-label uses : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2008)

Drug safety : an update from the Food and Drug Administration : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, second session, March 10, 2010.
Published: (2012)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

The Food and Drug Administration /
by: Patrick, William
Published: (1988)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

Prescription Drugs : FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials.
Published: (2007)

The future of drug safety : promoting and protecting the health of the public /
Published: (2007)

Drug Industry Antitrust Act : hearings before the United States House Committee on the Judiciary, Subcommittee on Antitrust, Eighty-Seventh Congress, second session, on May 17, 18, 23, 24, 1962.
Published: (1962)

FDA drug bulletin.
Published: (1971)

Review Panel on New Drug Regulation : final report.
Published: (1977)

Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)

Principal Differences Between the "Promoting Innovation and Access to Life-Saving Medicine Act" and the "Access to Life-Saving Medicine Act" Introduced in the 110th Congress.
Published: (2009)

Detailed Outline of the Promoting Innovations and Access to Life-Saving Medicine Act.
Published: (2009)

Q's and A's on the "Promoting Innovation and Access to Life-Saving Medicine Act".
Published: (2009)

Promoting Innovation and Access to Life-Saving Medicine Act.
Published: (2009)

Preliminary report of the survey on drugs for rare disease /
Published: (1982)

Drug compounding for animals : FDA could improve oversight with better information and guidance : report to congressional committees.
Published: (2015)

FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987.
Published: (1987)

FDA has made progress on oversight and inspections of manufacturers of generic drugs.
Published: (2015)

Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on Labor and Human Resources, United States Senate, One Hundred Fifth Congress, first session ... March 19 and April 11, 1997.
Published: (1997)

Drugs@FDA.

Competitive problems in the drug industry : drug testing : summary and analysis /
Published: (1979)

Forbidden cures. /
by: Fredman, Steven
Published: (1976)

"Man-in-the-plant" revisited, a deceptive drug labeling practice continues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980.
Published: (1980)